Larry Biegelsen Quotes

We suspect the new Boston Scientific offer was developed with input from the Guidant board, so it's likely that the Guidant board will declare it superior to J&J's latest offer. - Larry Biegelsen

We believe that Boston Scientific can raise its offer to $78 a share and still maintain an investment-grade credit rating. - Larry Biegelsen

In our view, Abbott is the clear winner in this deal. - Larry Biegelsen

Don't count BSX out yet. We expect BSX to continue to pursue GDT by potentially modifying or increasing its $72/share offer. - Larry Biegelsen

Although the strategic rationale for combining Boston Scientific and Guidant appears compelling, we have lingering concerns. - Larry Biegelsen

Page 1 of 1